.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Covington
US Army
Novartis
Cipla
AstraZeneca
UBS
Farmers Insurance
QuintilesIMS

Generated: November 19, 2017

DrugPatentWatch Database Preview

Patent Applications for ANGIOMAX

« Back to Dashboard

US Patent Applications for ANGIOMAX

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
► Subscribe► SubscribeFATTY ACID-PHARMACEUTICAL AGENT CONJUGATES2000-12-05Patented Case2003-05-21
► Subscribe► SubscribeMEDICAL DEVICE CONTAINING POLYHYDROXYALKANOATE TREATED WITH OXIDIZING AGENT TO REMOVE ENDOTOXIN2001-03-28Patented Case2003-09-04
► Subscribe► SubscribeDrug combinations and delivery devices for the prevention and treatment of vascular disease2001-05-07Abandoned -- Failure to Respond to an Office Action2008-04-30
► Subscribe► SubscribeTOPICAL AND TRANSDERMAL ADMINISTRATION OF PEPTIDYL DRUGS USING HYDROXIDE RELEASING AGENTS AS PERMEATION ENHANCERS2000-12-14Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622011-06-06
► Subscribe► SubscribeMethods and compositions of a BIOARTIFICIAL kidney suitable for use in vivo or ex vivo2001-02-28Abandoned -- Failure to Respond to an Office Action2003-01-10
► Subscribe► SubscribeIn vivo delivery methods and compositions2001-03-28Abandoned -- Failure to Respond to an Office Action2004-03-08
► Subscribe► SubscribeSURGICAL IRRIGATION SOLUTION AND METHOD FOR INHIBITION OF PAIN AND INFLAMMATION2001-04-17Patented Case2002-06-27
► Subscribe► SubscribeEXPANDABLE STENT WITH SLIDING AND LOCKING RADIAL ELEMENTS2000-12-14Patented Case2003-09-04
► Subscribe► SubscribeModified low molecular weight heparin that inhibits clot associated coagulation factors2001-06-06Abandoned -- Failure to Respond to an Office Action2003-11-03
► Subscribe► SubscribeHYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS2000-12-14Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-07-27
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Julphar
Fish and Richardson
Johnson and Johnson
Chubb
Teva
Healthtrust
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot